Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study - Concepedia

Concepedia

Publication | Closed Access

Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study

218

Citations

37

References

2010

Year

Leanne M. Ward, Frank Rauch, Michael P. Whyte, Phillip E. Gates, Dennis P. Grogan, Edward L. Lester, Richard E. McCall, Thomas A. Pressly, James O. Sanders, Peter A. Smith,

The Journal of Clinical Endocrinology & Metabolism

Abstract

Oral ALN for 2 yr in pediatric patients with OI significantly decreased bone turnover and increased spine areal BMD but was not associated with improved fracture outcomes.

References

	Year	Citations

Page 1